The global Clinical for CROs market size is expected to reach $ 89212 million by 2032, rising at a market growth of 3.9% CAGR during the forecast period (2026-2032).
Clinical CROs, as the name suggests, are contract research organizations that primarily provide technical services during drug clinical trials. Clinical CROs are responsible for clinical trial design, data management, registration and submission, and post-marketing drug safety monitoring. The global market size currently exceeds $65 billion, while the Chinese market exceeds $8 billion.
This report studies the global Clinical for CROs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Clinical for CROs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Clinical for CROs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Clinical for CROs total market, 2021-2032, (USD Million)
Global Clinical for CROs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Clinical for CROs total market, key domestic companies, and share, (USD Million)
Global Clinical for CROs revenue by player, revenue and market share 2021-2026, (USD Million)
Global Clinical for CROs total market by Type, CAGR, 2021-2032, (USD Million)
Global Clinical for CROs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Clinical for CROs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON plc, IQVIA Inc., Thermo Fisher Scientific, Syneos Health, Inc., Fortrea Holdings Inc, Parexel Inc, Medpace, Hangzhou Tigermed Consulting, CMIC Group, PSI CRO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Clinical for CROs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Clinical for CROs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Clinical for CROs Market, Segmentation by Type:
Clinical Trials and Management
Clinical Laboratory Services
Clinical Data Services
Clinical Consulting Services
Others
Global Clinical for CROs Market, Segmentation by Application:
Pharmaceuticals
Biotechnology
Medical Devices
Others
Companies Profiled:
ICON plc
IQVIA Inc.
Thermo Fisher Scientific
Syneos Health, Inc.
Fortrea Holdings Inc
Parexel Inc
Medpace
Hangzhou Tigermed Consulting
CMIC Group
PSI CRO
Ergomed
Caidya
Medelis
Celerion
Pharmaron Beijing
Key Questions Answered
1. How big is the global Clinical for CROs market?
2. What is the demand of the global Clinical for CROs market?
3. What is the year over year growth of the global Clinical for CROs market?
4. What is the total value of the global Clinical for CROs market?
5. Who are the Major Players in the global Clinical for CROs market?
6. What are the growth factors driving the market demand?

1 Supply Summary
1.1 Clinical for CROs Introduction
1.2 World Clinical for CROs Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Clinical for CROs Total Market by Region (by Headquarter Location)
1.3.1 World Clinical for CROs Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Clinical for CROs Revenue (2021-2032)
1.3.3 China Based Company Clinical for CROs Revenue (2021-2032)
1.3.4 Europe Based Company Clinical for CROs Revenue (2021-2032)
1.3.5 Japan Based Company Clinical for CROs Revenue (2021-2032)
1.3.6 South Korea Based Company Clinical for CROs Revenue (2021-2032)
1.3.7 ASEAN Based Company Clinical for CROs Revenue (2021-2032)
1.3.8 India Based Company Clinical for CROs Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Clinical for CROs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 Demand Summary
2.1 World Clinical for CROs Consumption Value (2021-2032)
2.2 World Clinical for CROs Consumption Value by Region
2.2.1 World Clinical for CROs Consumption Value by Region (2021-2026)
2.2.2 World Clinical for CROs Consumption Value Forecast by Region (2027-2032)
2.3 United States Clinical for CROs Consumption Value (2021-2032)
2.4 China Clinical for CROs Consumption Value (2021-2032)
2.5 Europe Clinical for CROs Consumption Value (2021-2032)
2.6 Japan Clinical for CROs Consumption Value (2021-2032)
2.7 South Korea Clinical for CROs Consumption Value (2021-2032)
2.8 ASEAN Clinical for CROs Consumption Value (2021-2032)
2.9 India Clinical for CROs Consumption Value (2021-2032)
3 World Clinical for CROs Companies Competitive Analysis
3.1 World Clinical for CROs Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Clinical for CROs Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Clinical for CROs in 2025
3.2.3 Global Concentration Ratios (CR8) for Clinical for CROs in 2025
3.3 Clinical for CROs Company Evaluation Quadrant
3.4 Clinical for CROs Market: Overall Company Footprint Analysis
3.4.1 Clinical for CROs Market: Region Footprint
3.4.2 Clinical for CROs Market: Company Product Type Footprint
3.4.3 Clinical for CROs Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 United States VS China VS Rest of World (by Headquarter Location)
4.1 United States VS China: Clinical for CROs Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Clinical for CROs Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Clinical for CROs Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Clinical for CROs Consumption Value Comparison
4.2.1 United States VS China: Clinical for CROs Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Clinical for CROs Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Clinical for CROs Companies and Market Share, 2021-2026
4.3.1 United States Based Clinical for CROs Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Clinical for CROs Revenue, (2021-2026)
4.4 China Based Companies Clinical for CROs Revenue and Market Share, 2021-2026
4.4.1 China Based Clinical for CROs Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Clinical for CROs Revenue, (2021-2026)
4.5 Rest of World Based Clinical for CROs Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Clinical for CROs Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Clinical for CROs Revenue (2021-2026)
5 Market Analysis by Type
5.1 World Clinical for CROs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Clinical Trials and Management
5.2.2 Clinical Laboratory Services
5.2.3 Clinical Data Services
5.2.4 Clinical Consulting Services
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Clinical for CROs Market Size by Type (2021-2026)
5.3.2 World Clinical for CROs Market Size by Type (2027-2032)
5.3.3 World Clinical for CROs Market Size Market Share by Type (2027-2032)
6 Market Analysis by Application
6.1 World Clinical for CROs Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 Pharmaceuticals
6.2.2 Biotechnology
6.2.3 Medical Devices
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Clinical for CROs Market Size by Application (2021-2026)
6.3.2 World Clinical for CROs Market Size by Application (2027-2032)
6.3.3 World Clinical for CROs Market Size Market Share by Application (2021-2032)
7 Company Profiles
7.1 ICON plc
7.1.1 ICON plc Details
7.1.2 ICON plc Major Business
7.1.3 ICON plc Clinical for CROs Product and Services
7.1.4 ICON plc Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 ICON plc Recent Developments/Updates
7.1.6 ICON plc Competitive Strengths & Weaknesses
7.2 IQVIA Inc.
7.2.1 IQVIA Inc. Details
7.2.2 IQVIA Inc. Major Business
7.2.3 IQVIA Inc. Clinical for CROs Product and Services
7.2.4 IQVIA Inc. Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 IQVIA Inc. Recent Developments/Updates
7.2.6 IQVIA Inc. Competitive Strengths & Weaknesses
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Details
7.3.2 Thermo Fisher Scientific Major Business
7.3.3 Thermo Fisher Scientific Clinical for CROs Product and Services
7.3.4 Thermo Fisher Scientific Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Thermo Fisher Scientific Recent Developments/Updates
7.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.4 Syneos Health, Inc.
7.4.1 Syneos Health, Inc. Details
7.4.2 Syneos Health, Inc. Major Business
7.4.3 Syneos Health, Inc. Clinical for CROs Product and Services
7.4.4 Syneos Health, Inc. Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Syneos Health, Inc. Recent Developments/Updates
7.4.6 Syneos Health, Inc. Competitive Strengths & Weaknesses
7.5 Fortrea Holdings Inc
7.5.1 Fortrea Holdings Inc Details
7.5.2 Fortrea Holdings Inc Major Business
7.5.3 Fortrea Holdings Inc Clinical for CROs Product and Services
7.5.4 Fortrea Holdings Inc Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Fortrea Holdings Inc Recent Developments/Updates
7.5.6 Fortrea Holdings Inc Competitive Strengths & Weaknesses
7.6 Parexel Inc
7.6.1 Parexel Inc Details
7.6.2 Parexel Inc Major Business
7.6.3 Parexel Inc Clinical for CROs Product and Services
7.6.4 Parexel Inc Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Parexel Inc Recent Developments/Updates
7.6.6 Parexel Inc Competitive Strengths & Weaknesses
7.7 Medpace
7.7.1 Medpace Details
7.7.2 Medpace Major Business
7.7.3 Medpace Clinical for CROs Product and Services
7.7.4 Medpace Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Medpace Recent Developments/Updates
7.7.6 Medpace Competitive Strengths & Weaknesses
7.8 Hangzhou Tigermed Consulting
7.8.1 Hangzhou Tigermed Consulting Details
7.8.2 Hangzhou Tigermed Consulting Major Business
7.8.3 Hangzhou Tigermed Consulting Clinical for CROs Product and Services
7.8.4 Hangzhou Tigermed Consulting Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Hangzhou Tigermed Consulting Recent Developments/Updates
7.8.6 Hangzhou Tigermed Consulting Competitive Strengths & Weaknesses
7.9 CMIC Group
7.9.1 CMIC Group Details
7.9.2 CMIC Group Major Business
7.9.3 CMIC Group Clinical for CROs Product and Services
7.9.4 CMIC Group Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 CMIC Group Recent Developments/Updates
7.9.6 CMIC Group Competitive Strengths & Weaknesses
7.10 PSI CRO
7.10.1 PSI CRO Details
7.10.2 PSI CRO Major Business
7.10.3 PSI CRO Clinical for CROs Product and Services
7.10.4 PSI CRO Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 PSI CRO Recent Developments/Updates
7.10.6 PSI CRO Competitive Strengths & Weaknesses
7.11 Ergomed
7.11.1 Ergomed Details
7.11.2 Ergomed Major Business
7.11.3 Ergomed Clinical for CROs Product and Services
7.11.4 Ergomed Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Ergomed Recent Developments/Updates
7.11.6 Ergomed Competitive Strengths & Weaknesses
7.12 Caidya
7.12.1 Caidya Details
7.12.2 Caidya Major Business
7.12.3 Caidya Clinical for CROs Product and Services
7.12.4 Caidya Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 Caidya Recent Developments/Updates
7.12.6 Caidya Competitive Strengths & Weaknesses
7.13 Medelis
7.13.1 Medelis Details
7.13.2 Medelis Major Business
7.13.3 Medelis Clinical for CROs Product and Services
7.13.4 Medelis Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 Medelis Recent Developments/Updates
7.13.6 Medelis Competitive Strengths & Weaknesses
7.14 Celerion
7.14.1 Celerion Details
7.14.2 Celerion Major Business
7.14.3 Celerion Clinical for CROs Product and Services
7.14.4 Celerion Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 Celerion Recent Developments/Updates
7.14.6 Celerion Competitive Strengths & Weaknesses
7.15 Pharmaron Beijing
7.15.1 Pharmaron Beijing Details
7.15.2 Pharmaron Beijing Major Business
7.15.3 Pharmaron Beijing Clinical for CROs Product and Services
7.15.4 Pharmaron Beijing Clinical for CROs Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Pharmaron Beijing Recent Developments/Updates
7.15.6 Pharmaron Beijing Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Clinical for CROs Industry Chain
8.2 Clinical for CROs Upstream Analysis
8.3 Clinical for CROs Midstream Analysis
8.4 Clinical for CROs Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer